Potential Role of H-Ferritin in Mitigating Valvular Mineralization
| Autor: | Maura Poli, Abolfazl Zarjou, Niké Posta, Tamás Szerafin, Lívia Beke, László Potor, József Balla, György Balla, Anupam Agarwal, Melinda Oros, Gábor Méhes, Zoltán Hendrik, Katalin Éva Sikura, Ibolya Fürtös, Paolo Arosio |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
0301 basic medicine
Aortic valve medicine.medical_specialty Iron Interleukin-1beta Core Binding Factor Alpha 1 Subunit Thiophenes 030204 cardiovascular system & hematology Ferroxidase activity Klinikai orvostudományok Article Ion Channels Interstitial cell Phosphates Pathogenesis 03 medical and health sciences 0302 clinical medicine Internal medicine medicine Vascular Calcification Cells Cultured Cell Nucleus biology Phosphoric Diester Hydrolases Tumor Necrosis Factor-alpha Chemistry Endothelial Cells Thiones Biological Transport SOX9 Transcription Factor Aortic Valve Stenosis Orvostudományok medicine.disease Ferritin 030104 developmental biology medicine.anatomical_structure Endocrinology Gene Expression Regulation Aortic Valve Apoferritins Osteocalcin biology.protein Lysosomes Cardiology and Cardiovascular Medicine Ceruloplasmin Calcification |
| Popis: | Objective— Calcific aortic valve disease is a prominent finding in elderly and in patients with chronic kidney disease. We investigated the potential role of iron metabolism in the pathogenesis of calcific aortic valve disease. Approach and Results— Cultured valvular interstitial cells of stenotic aortic valve with calcification from patients undergoing valve replacement exhibited significant susceptibility to mineralization/osteoblastic transdifferentiation in response to phosphate. This process was abrogated by iron via induction of H-ferritin as reflected by lowering ALP and osteocalcin secretion and preventing extracellular calcium deposition. Cellular phosphate uptake and accumulation of lysosomal phosphate were decreased. Accordingly, expression of phosphate transporters Pit1 and Pit2 were repressed. Translocation of ferritin into lysosomes occurred with high phosphate-binding capacity. Importantly, ferritin reduced nuclear accumulation of RUNX2 (Runt-related transcription factor 2), and as a reciprocal effect, it enhanced nuclear localization of transcription factor Sox9 (SRY [sex-determining region Y]-box 9). Pyrophosphate generation was also increased via upregulation of ENPP2 (ectonucleotide pyrophosphatase/phosphodiesterase-2). 3 H-1, 2-dithiole-3-thione mimicked these beneficial effects in valvular interstitial cell via induction of H-ferritin. Ferroxidase activity of H-ferritin was essential for this function, as ceruloplasmin exhibited similar inhibitory functions. Histological analysis of stenotic aortic valve revealed high expression of H-ferritin without iron accumulation and its relative dominance over ALP in noncalcified regions. Increased expression of H-ferritin accompanied by elevation of TNF-α (tumor necrosis factor-α) and IL-1β (interleukin-1β) levels, inducers of H-ferritin, corroborates the essential role of ferritin/ferroxidase via attenuating inflammation in calcific aortic valve disease. Conclusions— Our results indicate that H-ferritin is a stratagem in mitigating valvular mineralization/osteoblastic differentiation. Utilization of 3H-1, 2-dithiole-3-thione to induce ferritin expression may prove a novel therapeutic potential in valvular mineralization. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|